5-oxo-5, 8-dihydropyrido [2, 3-d] pyrimidine derivatives as CaMKII kinase inhibitors for treating cardiovascular diseases

Details for Australian Patent Application No. 2011206475 (hide)

Owner Sanofi

Inventors Beauverger, Philippe; Begis, Guillaume; Biscarrat, Sandrine; Duclos, Olivier; McCort, Gary

Agent A J Park

Pub. Number AU-A-2011206475

PCT Pub. Number WO2011/086306

Priority 1050103 08.01.10 FR

Filing date 6 January 2011

Wipo publication date 21 July 2011

International Classifications

C07D 471/04 Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

A61K 31/519 - ortho- or peri-condensed with heterocyclic rings

A61P 9/00 Drugs for disorders of the cardiovascular system

Event Publications

2 August 2012 PCT application entered the National Phase

  PCT publication WO2011/086306 Priority application(s): WO2011/086306

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011206524-CVD single crystal diamond material

2011206464-System for managing and controlling photovoltaic panels